Description

A biotech with a life changing test. It's up 186% so far this year and still managed to surge 15% this week. Jim Cramer sat down with CEO Kevin Conroy to see what’s next.» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC» Watch more Mad Money here: http://bit.ly/WatchMadMoney» Read more about Exact Sciences here: http://cnb.cx/2s3eODZ"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.Get More Mad Money!Read the latest news: http://madmoney.cnbc.com Watch full episodes: http://bit.ly/MadMoneyEpisodesFollow Mad Money on Twitter: http://bit.ly/MadMoneyTwitterLike Mad Money on Facebook: http://bit.ly/LikeMadMoneyFollow Cramer on Twitter: http://bit.ly/FollowCramerConnect with CNBC News Online!Visit CNBC.com: http://www.cnbc.com/Find CNBC News on Facebook: http://cnb.cx/LikeCNBCFollow CNBC News on Twitter: http://cnb.cx/FollowCNBCFollow CNBC News on Google+: http://cnb.cx/PlusCNBCFollow CNBC News on Instagram: http://cnb.cx/InstagramCNBC Exact Sciences CEO: Detecting Cancer | Mad Money | CNBC

Tags

CNBC business news finance news channel news station breaking news us news world news cable cable news finance news money money tips mad money (tv program) Jim Cramer stock advice Jim Cramer interview CEO interview interview mad money interview stock market stock performance market news stock picks Exact Sciences CEO cancer research non invasive colon cancer screening exact sciences cologuard exact sciences stock biotech stocks